The "Peripherally Inserted Central Catheter (PICC) Line Fever" Workup: A Structured Diagnostic Algorithm for the Febrile Patient
Dr Neeraj manikath , claude,ai
Abstract
Fever in patients with peripherally inserted central catheters (PICC) presents a diagnostic challenge, requiring clinicians to distinguish between catheter-related bloodstream infections (CRBSI), catheter colonization, and non-catheter sources. Premature line removal increases costs, procedural risks, and venous access depletion, while delayed removal in true central line-associated bloodstream infections (CLABSI) increases morbidity and mortality. This review presents a structured 24-hour diagnostic algorithm emphasizing differential time to positivity (DTP), appropriate culture techniques, clinical assessment parameters, and evidence-based criteria for line salvage versus removal. We synthesize current guidelines from the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), and critical care literature to provide postgraduate physicians with a practical, stepwise approach to this common clinical scenario.
Keywords: PICC line, CLABSI, differential time to positivity, catheter-related bloodstream infection, fever workup, antibiotic lock therapy
Introduction
Peripherally inserted central catheters have become ubiquitous in modern medicine, with over 5 million PICC lines placed annually in the United States alone.1 These devices provide reliable central venous access for prolonged antimicrobial therapy, parenteral nutrition, chemotherapy, and frequent blood sampling while theoretically reducing complications associated with traditional central venous catheters. However, PICC lines are not without risk—infection rates range from 1.1 to 2.1 per 1,000 catheter-days, with catheter-related bloodstream infections contributing significantly to healthcare costs, length of stay, and patient mortality.2,3
When a patient with a PICC line develops fever, the clinician faces a critical decision tree: Is the fever related to the line? If so, is it colonization, local infection, or bloodstream infection? Should the line be removed immediately or can it be salvaged? These questions must be answered rapidly yet accurately, as unnecessary line removal depletes venous access and increases procedural complications, while delayed removal in true CLABSI can lead to septic thrombophlebitis, endocarditis, and septic shock.
This review presents a structured 24-hour diagnostic algorithm that optimizes the workup of PICC line fever, emphasizing the differential time to positivity technique, systematic clinical assessment, and evidence-based criteria for line management. Our goal is to provide postgraduate physicians with actionable tools to navigate this common clinical scenario with confidence and precision.
Defining the Problem: CLABSI, CRBSI, and Colonization
Terminology Matters
Understanding the fever workup requires precise terminology. The Centers for Disease Control and Prevention (CDC) defines CLABSI (Central Line-Associated Bloodstream Infection) as a laboratory-confirmed bloodstream infection in a patient with a central line in place for more than two calendar days, where the infection is not related to another site.4 This surveillance definition, while useful for epidemiology, lacks specificity for bedside diagnosis.
Clinically, we use CRBSI (Catheter-Related Bloodstream Infection), which requires microbiological evidence linking the catheter to the bloodstream infection. The IDSA defines definitive CRBSI as isolation of the same organism from both a catheter segment culture (typically >15 colony-forming units by semiquantitative culture) and a peripheral blood culture in a patient with clinical signs of infection and no other apparent source.5
Catheter colonization refers to significant microbial growth from the catheter (>15 CFU) without associated bloodstream infection or clinical signs of infection. Colonization is common, occurring in 15-35% of catheters, but rarely requires line removal or treatment.6
Exit site infection manifests as erythema, tenderness, induration, or purulent drainage within 2 cm of the exit site. Tunnel infection involves tenderness, erythema, and induration along the subcutaneous tract of the catheter, typically more than 2 cm from the exit site.7
The 24-Hour Diagnostic Algorithm: Step-by-Step Approach
Step 1: Simultaneous Blood Cultures—The Differential Time to Positivity
The cornerstone of diagnosing catheter-related bloodstream infection without removing the line is the differential time to positivity (DTP) technique. This elegant method compares the time required for blood cultures drawn simultaneously from the catheter and a peripheral vein to turn positive.
Technique:
When fever develops (temperature ≥38.0°C or 100.4°F), draw blood cultures simultaneously—one set (aerobic and anaerobic bottles) from the PICC line and one set from a peripheral vein before initiating or changing antibiotics. Label specimens clearly with draw time and source. Ensure adequate blood volume (8-10 mL per bottle for adults).8
Interpretation:
If the PICC-drawn culture turns positive ≥2 hours before the peripheral culture, the sensitivity for CRBSI is 85-91% with specificity of 87-94%.9,10 The pathophysiology is straightforward: higher bacterial burden exists within the catheter biofilm than in peripheral circulation, leading to earlier microbial detection in the catheter-drawn sample.
Pearl: DTP requires continuous monitoring systems or automated blood culture instruments. Manual inspection is unreliable. The 2-hour cutoff (120 minutes) is the validated threshold, though some studies suggest >90 minutes may have acceptable accuracy.11
Oyster: False positives occur if peripheral cultures are drawn incorrectly (e.g., inadequate skin antisepsis leading to skin flora contamination) or if blood volume is inadequate in the peripheral sample. False negatives occur in patients already on antibiotics, with low-grade bacteremia, or with biofilm organisms that grow slowly.
Step 2: Meticulous Exit Site and Tunnel Examination
Physical examination remains fundamental. Remove all dressings and inspect the entire visible catheter tract.
Exit Site Assessment:
- Purulent drainage: Obtain culture via swab or aspiration. Purulence indicates exit site infection requiring line removal in most cases.
- Erythema: Measure and document size. Erythema <2 cm may represent mild inflammation; >2 cm suggests infection.
- Tenderness: Localized tenderness at the exit correlates with local infection.
- Induration: Firmness suggests deeper soft tissue involvement.
Tunnel Assessment:
Palpate along the subcutaneous tract from exit site toward the venous insertion point. Tenderness, erythema, or fluctuance indicates tunnel infection, which requires line removal and prolonged antibiotic therapy (4-6 weeks if complicated).12
Pearl: Use ultrasound to identify fluid collections along the tunnel tract. Small abscesses may not be palpable but significantly alter management.
Hack: Document findings with photographs when possible, particularly for teaching hospitals or medicolegal purposes, and to track evolution over subsequent examinations.
Step 3: Basic Laboratory and Imaging Studies
Laboratory Studies:
- Complete Blood Count (CBC): Leukocytosis supports infection but is nonspecific. Neutropenia increases infection risk but may blunt leukocyte response.
- C-Reactive Protein (CRP): Elevated CRP (>10 mg/L) suggests inflammation but doesn't distinguish infection source. Serial measurements help track treatment response.
- Procalcitonin: More specific than CRP for bacterial infection. Levels >0.5 ng/mL suggest bacterial sepsis; >2.0 ng/mL indicates severe bacterial infection or sepsis. Useful for antibiotic stewardship decisions.13
- Blood chemistries: Assess organ dysfunction (creatinine, liver enzymes) and guide antibiotic dosing.
Imaging:
- Chest X-Ray: Essential to evaluate for pneumonia, which commonly coexists or masquerades as PICC fever. Also assesses line position and identifies rare complications like catheter migration or thrombosis.
- Venous Ultrasound: Consider if clinical suspicion exists for catheter-associated thrombosis, which occurs in 2-5% of PICC lines and predisposes to CRBSI.14 Thrombus management is controversial but generally involves anticoagulation and line removal if infected.
- Advanced Imaging: CT with contrast or MRI if deep-seated infection (endocarditis, epidural abscess, septic emboli) is suspected, particularly with persistent bacteremia despite appropriate therapy.
Oyster: Normal inflammatory markers don't exclude infection, especially in immunocompromised patients or early infection. Clinical gestalt remains paramount.
Step 4: The Antibiotic Conundrum—To Treat or Not to Treat Empirically
A critical but often overlooked principle: hold empiric antibiotics until blood cultures are obtained if the patient is hemodynamically stable without signs of severe sepsis or septic shock.
Rationale:
Premature antibiotics decrease culture yield by 30-50% and may mask true infection, leading to diagnostic uncertainty and prolonged empiric therapy.15 If infection is present, a few hours' delay while obtaining cultures rarely worsens outcomes in stable patients but significantly improves diagnostic accuracy.
Exceptions—Initiate Empiric Antibiotics Immediately if:
- Sepsis or septic shock (per Surviving Sepsis Campaign criteria16)
- Severe immunosuppression (absolute neutrophil count <500 cells/μL)
- High clinical suspicion for aggressive pathogens (purulent exit site drainage, tunnel infection)
- Prosthetic device or endovascular hardware (increased risk of metastatic infection)
Empiric Regimen Selection:
When empiric coverage is necessary, tailor to local antibiograms and patient-specific risk factors:
Standard Empiric Regimen:
- Vancomycin 15-20 mg/kg IV loading dose, then dosed by pharmacy protocol to achieve trough 15-20 μg/mL (covers MRSA, coagulase-negative staphylococci)
- Piperacillin-Tazobactam 4.5 g IV every 6 hours (or extended infusion 3.375 g over 4 hours every 8 hours) covers gram-negative organisms including Pseudomonas
Modifications:
- Penicillin allergy: Substitute aztreonam 2 g IV every 8 hours for gram-negative coverage
- Carbapenem-resistant Enterobacteriaceae (CRE) risk: Add meropenem 1-2 g IV every 8 hours or ceftazidime-avibactam
- Candidemia risk (TPN, prolonged broad-spectrum antibiotics, colonization): Add fluconazole 800 mg loading dose, then 400 mg daily, or echinocandin (micafungin 100 mg daily) if azole resistance suspected17
Antibiotic Stewardship Pearl: De-escalate therapy within 48-72 hours based on culture results and clinical response. Broad-spectrum empiric coverage should not continue beyond this window without documented resistant organisms.
Step 5: The Critical Decision—To Pull or Not to Pull
This decision determines outcomes. The answer depends on organism identity, clinical severity, response to therapy, and feasibility of alternative access.
Definite Indications for Line Removal
Organism-Related:
- Staphylococcus aureus (methicillin-sensitive or resistant): Associated with high rates of metastatic infection (endocarditis, osteomyelitis, epidural abscess) even with appropriate antibiotics. Retain line only in extraordinary circumstances with infectious disease consultation.18
- Pseudomonas aeruginosa: Forms robust biofilm resistant to systemic antibiotics. Line removal required for source control.19
- Candida species: Fungal biofilms are recalcitrant to antifungal therapy. Retained catheters lead to persistent fungemia and increased mortality.20
- Resistant gram-negative organisms (extended-spectrum beta-lactamase producers, CRE): Biofilm penetration by appropriate antibiotics is suboptimal; line removal improves clearance rates.
Clinical Scenario-Related:
5. Severe sepsis or septic shock: Source control is critical. Remove line and place new access after resuscitation.
6. Persistent bacteremia: Positive blood cultures persisting >72 hours despite appropriate therapy suggest metastatic infection or inadequate source control.
7. Tunnel infection or pocket infection: Antibiotics cannot adequately penetrate these deep soft tissue infections.
8. Suppurative thrombophlebitis: Fever and positive cultures with documented venous thrombosis mandate line removal, anticoagulation, and consideration for surgical debridement if septic emboli occur.21
9. Exit site with purulent drainage unless clearly superficial and easily managed with local care.
Conditional Indications—Line Salvage May Be Attempted
Coagulase-Negative Staphylococci (CoNS):
This is the most common PICC isolate, accounting for 40-50% of CLABSI cases. CoNS, particularly Staphylococcus epidermidis, are low-virulence organisms that rarely cause metastatic complications. Line salvage is reasonable if:22
- Patient is hemodynamically stable
- No evidence of tunnel infection or suppurative thrombophlebitis
- Blood cultures clear within 72 hours of appropriate antibiotics
- Systemic antibiotics combined with antibiotic lock therapy (ALT) are administered
Antibiotic Lock Therapy (ALT) Technique:
ALT involves instilling high-concentration antibiotics into the catheter lumen, dwelling for 12-24 hours, then aspirating before use. This achieves concentrations 100-1000× higher than serum levels, penetrating biofilm effectively.23
Standard ALT Protocol for CoNS:
- Vancomycin 2-5 mg/mL (prepare by adding vancomycin to normal saline to fill catheter volume, typically 1-3 mL)
- Instill into each lumen after blood draw and medication administration
- Dwell time: 12-24 hours
- Duration: 10-14 days concurrent with systemic antibiotics
Hack: Some institutions use ethanol lock therapy (70% ethanol) as an alternative, with excellent biofilm penetration and broad antimicrobial spectrum. However, ethanol can damage polyurethane catheters; verify catheter compatibility.24
Enterococcus species: Generally low virulence; salvage may be attempted in stable patients, especially if access is limited and organism is susceptible to systemic therapy.
Gram-Negative Bacilli (except Pseudomonas): Salvage success varies. E. coli and Klebsiella CLABSI may respond to systemic antibiotics plus ALT if patient is stable and cultures clear rapidly. Close monitoring is essential; failure to clear bacteremia within 72 hours mandates line removal.25
The "Impossible Vascular Access" Patient
Occasionally, patients have exhausted venous access options, making line preservation critical. In these scenarios:
- Infectious disease consultation is mandatory
- Consider guidewire exchange to fresh PICC with new insertion site if technically feasible
- Extended antibiotic courses (4-6 weeks) with close monitoring
- Document shared decision-making with patient regarding risks
- Serial blood cultures every 48-72 hours to confirm clearance
- Low threshold for line removal if clinical deterioration occurs
Pearls, Oysters, and Clinical Hacks
Pearl 1: The "Fever Curve" Pattern
Catheter-related infections often produce fever spikes temporally related to catheter access. If fever consistently occurs within 1-2 hours of flushing or accessing the line, suspect CRBSI even with negative cultures (biofilm release phenomenon).
Pearl 2: Quantitative Cultures
If available, request quantitative blood cultures. A colony count ≥5:1 (catheter-drawn/peripheral) is diagnostic for CRBSI with 79% sensitivity and 99% specificity.26 This complements DTP when automated systems don't provide exact timing.
Pearl 3: The "Wait-and-Watch" in Contamination
Single positive blood culture with skin flora (CoNS, Bacillus, Corynebacterium) likely represents contamination if patient is well-appearing. Repeat cultures before initiating therapy. True CLABSI with these organisms usually produces multiple positive cultures.
Oyster 1: The Immunocompromised Patient
Neutropenic or severely immunocompromised patients may not mount fever or localizing signs. Lower threshold for empiric antibiotics and line removal. Consider adding empiric antifungal coverage if risk factors present.
Oyster 2: The Persistent Low-Grade Fever
Temperature 37.5-38.0°C without localizing signs may represent non-infectious catheter-related thrombosis, drug fever, or transfusion reaction. Avoid reflexive antibiotic escalation; pursue alternative diagnoses systematically.
Oyster 3: False Security with Negative Cultures
Negative blood cultures don't exclude CRBSI, particularly if antibiotics were started before culture draw, or if patient has culture-negative endocarditis. Clinical judgment supersedes laboratory data.
Hack 1: The "Two-Site Two-Time" Rule
Always draw peripheral cultures from different sites (bilateral arms) to distinguish contamination from true bacteremia. Contamination rarely occurs bilaterally with identical organisms.
Hack 2: Biomarker-Guided De-escalation
Use procalcitonin to guide antibiotic duration. If procalcitonin drops >80% from peak by day 3-4, infection is responding; if plateau or rise occurs, suspect resistant organism, inadequate source control, or alternative diagnosis.27
Hack 3: The "Antibiotic Holiday" Assessment
In stable patients with resolving fever on antibiotics but uncertain diagnosis, consider 48-hour antibiotic holiday with close monitoring. Recrudescent fever suggests persistent infection requiring further investigation or line removal.
The 24-Hour Decision Flowchart
Hour 0: Patient develops fever ≥38.0°C with PICC line in place
- Draw simultaneous blood cultures (PICC and peripheral) before antibiotics
- Examine exit site and tunnel thoroughly
- Obtain CBC, CRP/procalcitonin, basic metabolic panel
- Chest X-ray
Hours 0-6: Clinical assessment phase
- If septic shock/severe sepsis: Start empiric antibiotics immediately, consider line removal
- If stable: Hold antibiotics pending culture results
- Document differential diagnosis (pneumonia, UTI, drug fever, etc.)
Hours 6-24: Monitoring phase
- Monitor DTP on automated culture system
- Assess clinical trajectory (improving vs. deteriorating)
- Review preliminary culture results (gram stain at 12-18 hours)
Hour 24: Decision point
- DTP positive (>2 hours) + gram-positive cocci: Likely CoNS—consider salvage with systemic antibiotics + ALT if stable
- DTP positive + gram-positive cocci in clusters: Possible S. aureus—remove line
- DTP positive + gram-negative rods: Likely Pseudomonas or Enterobacteriaceae—remove line unless stable with susceptible E. coli/Klebsiella (attempt salvage with caution)
- DTP positive + yeast: Remove line immediately
- DTP negative but clinical suspicion high: Pursue alternative diagnoses; consider venous ultrasound for thrombosis
- Cultures negative at 48 hours, patient improving: Consider non-infectious fever; discontinue empiric antibiotics
Treatment Duration
Once organism identification and susceptibilities return, tailor antibiotic duration to organism and clinical response:
- Coagulase-negative staphylococci (uncomplicated CLABSI, line removed): 5-7 days
- Coagulase-negative staphylococci (line retained with ALT): 10-14 days systemic + ALT
- S. aureus (uncomplicated bacteremia, line removed): 14 days; obtain echocardiogram to exclude endocarditis28
- S. aureus with metastatic complications: 4-6 weeks
- Gram-negative bacteremia (uncomplicated, line removed): 7-14 days depending on organism and source control
- Candida (line removed): 14 days after documented clearance of candidemia; ophthalmologic examination to exclude endophthalmitis29
Prevention: Reducing PICC Line Infections
While outside the scope of acute management, prevention deserves mention:
- Appropriate indication assessment: Use Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) criteria to avoid unnecessary PICC placement30
- Chlorhexidine-impregnated dressings: Reduce colonization and CLABSI rates
- Ultrasound-guided placement: Reduces insertion attempts and complications
- Chlorhexidine bath protocols: Daily bathing in ICU patients reduces CLABSI
- Prompt removal: Remove PICC lines when no longer indicated; every additional day increases infection risk
Conclusion
The febrile patient with a PICC line demands systematic evaluation balancing the risks of unnecessary line removal against delayed source control. The 24-hour diagnostic algorithm presented here—emphasizing simultaneous blood cultures with differential time to positivity, meticulous physical examination, judicious empiric antibiotic use, and evidence-based criteria for line retention versus removal—provides a structured framework for this common clinical challenge.
Key takeaways for the postgraduate physician:
- Draw simultaneous cultures before antibiotics whenever possible
- DTP ≥2 hours strongly suggests CRBSI
- Remove lines for S. aureus, Pseudomonas, Candida, tunnel infection, or persistent bacteremia
- Consider salvage for CoNS in stable patients with systemic antibiotics plus antibiotic lock therapy
- Don't anchor on the line—systematically evaluate alternative fever sources
Mastering this approach reduces unnecessary line removal, optimizes antibiotic stewardship, and improves patient outcomes while preserving precious vascular access for those who need it most.
References
-
Chopra V, Flanders SA, Saint S, et al. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med. 2015;163(6 Suppl):S1-S40.
-
Chopra V, O'Horo JC, Rogers MA, et al. The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2013;34(9):908-918.
-
Marschall J, Mermel LA, Fakih M, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(7):753-771.
-
Centers for Disease Control and Prevention. Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection). January 2023.
-
Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1-45.
-
Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis. 2007;7(10):645-657.
-
Safdar N, Maki DG. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med. 2002;30(12):2632-2635.
-
Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24(4):584-602.
-
Blot F, Nitenberg G, Chachaty E, et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet. 1999;354(9184):1071-1077.
-
Raad I, Hanna HA, Alakech B, et al. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med. 2004;140(1):18-25.
-
Catton JA, Dobbins BM, Kite P, et al. In situ diagnosis of intravascular catheter-related bloodstream infection: a comparison of quantitative culture, differential time to positivity, and endoluminal brushing. Crit Care Med. 2005;33(4):787-791.
-
Fowler VG Jr, Justice A, Moore C, et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis. 2005;40(5):695-703.
-
Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017;10(10):CD007498.
-
Evans RS, Sharp JH, Linford LH, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest. 2010;138(4):803-810.
-
Cheng MP, Stenstrom R, Paquette K, et al. Blood culture results before and after antimicrobial administration in patients with severe manifestations of sepsis: a diagnostic study. Ann Intern Med. 2019;171(8):547-554.
-
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063-e1143.
-
Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-e50.
-
Fowler VG Jr, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis. 1998;27(3):478-486.
-
Høiby N, Bjarnsholt T, Givskov M, et al. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35(4):322-332.
-
Andes DR, Safdar N, Baddley JW, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54(8):1110-1122.
-
Muñoz P, Fernández-Cruz A, Usubillaga R, et al. Central venous catheter-related septic thrombophlebitis. Curr Infect Dis Rep. 2003;5(5):413-419.
-
Raad I, Kassar R, Ghannam D, et al. Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis. 2009;49(8):1187-1194.
-
Mermel LA, Alang N. Adverse effects associated with ethanol catheter lock solutions: a systematic review. J Antimicrob Chemother. 2014;69(10):2611-2619.
-
Crnich CJ, Maki DG. Are antimicrobial-impregnated catheters effective? Don't throw out the baby with the bathwater. Clin Infect Dis. 2004;38(9):1287-1292.
-
Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother. 2005;55(1):90-94.
-
Quilici N, Audibert G, Conroy MC, et al. Differential quantitative blood cultures in the diagnosis of catheter-related sepsis in intensive care units. Clin Infect Dis. 1997;25(5):1066-1070.
-
de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16(7):819-827.
-
Holland TL, Arnold C, Fowler VG Jr. Clinical management of Staphylococcus aureus bacteremia: a review. JAMA. 2014;312(13):1330-1341.
-
Pappas PG, Lionakis MS, Arendrup MC, et al. Invasive candidiasis. Nat Rev Dis Primers. 2018;4:18026.
-
Swaminathan L, Flanders S, Rogers M, et al. Improving PICC use and outcomes in hospitalised patients: an interrupted time series study using MAGIC criteria. BMJ Qual Saf. 2018;27(4):271-278.
Disclosure Statement: The author reports no conflicts of interest related to this manuscript.
Word Count: 3,015
